In the realm of "pure science", EncorePharma's professionals have published original research in a variety of disciplines, including synthetic medicinal chemistry, biochemistry, biology, immunology, and biotechnology. Among members of the scientific community, several of our investigators are recognized as international leaders in their research fields.

In addition, EncorePharma professionals are experienced in many aspects of pre-clinical research, including in vivo and in vitro biological studies. Clinically, our current areas of therapeutic interest are oncology, Alzheimer's Disease, cardiovascular diseases, immunology (allergy/asthma), arthritis, and periodontal disease. However, our scientists possess a breadth of experience that allows for expansion into many therapeutic specializations or sub specializations.

EncorePharma  is committed to developing its own intellectual property from laboratory bench through early clinical evaluation. Through the development of its intellectual property, EncorePharma has broadened its in-house R&D operations to include research collaborations with several important academic and industrial organizations worldwide in a number of therapeutic areas.